Question 1

How many shares of ARWR does FARALLON CAPITAL MANAGEMENT, L.L.C. own?

Accepted Answer

FARALLON CAPITAL MANAGEMENT, L.L.C. previously held 0 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN) before exiting the position in 2026-Q2.

Question 2

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s ARWR position worth?

Accepted Answer

FARALLON CAPITAL MANAGEMENT, L.L.C.'s ARWR position was last reported at $0 in 2026-Q2 before the exit.

Question 3

Is FARALLON CAPITAL MANAGEMENT, L.L.C. buying or selling ARWR?

Accepted Answer

In 2026-Q2, FARALLON CAPITAL MANAGEMENT, L.L.C. exited their ARWR position entirely (-100.0% change in shares).

Question 4

When did FARALLON CAPITAL MANAGEMENT, L.L.C. first buy ARWR?

Accepted Answer

Based on available 13F filings, FARALLON CAPITAL MANAGEMENT, L.L.C. first reported a position in ARWR in 2024-Q4. They have held the position across 24 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$81.51	0
2026-Q1	Unchanged	15,800	0.0%	$990,660	0.0%	$64.10	0
2025-Q4	Unchanged	15,800	0.0%	$1M	0.0%	$67.25	0
2025-Q3	Unchanged	15,800	0.0%	$544,942	0.0%	$33.78	0
2025-Q2	Unchanged	15,800	0.0%	$249,640	0.0%	$16.08	0
2025-Q1	Decreased	15,800	-97.5%	$201,292	0.0%	$13.82	0
2024-Q4	New	628,800	—	$11.8M	0.1%	$18.61	39